Table 5.

Echocardiographic assessment of mouse cardiovascular function in response to intravenous hRFRP-1 at 5 minutes (* denotes statistical significance from control, p < 0.05).

	% Change (mean ± SEM)
	HR	SV	EF %	CO
Saline	−17 ± 6%	17 ± 3%	32% ± 3%	−20 ± 2%
500 ηmol/kg bw hRFRP-1	−25 ± 2%	−28 ± 10%*	−33% ± 10%*	−44 ± 9%*
5 μmol/kg bw hRFRP-1	−54 ± 7%*	−57 ± 9%*	−49% ± 8%*	−79 ± 7%*